期刊
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
卷 75, 期 -, 页码 58-63出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.yjmcc.2014.06.018
关键词
ERK; SERCA2; NF-kappaB; Neonatal rat ventricular myocytes; Cardiac hypertrophy; Cardiovascular disease
资金
- NIH [1K08HL105801, 1R01HL122309]
- Lewis Katz Prize in Cardiovascular Research
Pathologic cardiac hypertrophy can lead to heart failure, but the mechanisms involved are poorly understood. SERCA2 is critical for normal cardiac calcium handling and function and SERCA2 mRNA and protein levels are reduced by cardiac hypertrophy. We hypothesized that extracellular signal-regulated kinase (ERK) 1/2 activation during hypertrophy reduced SERCA2 transcription. Using a neonatal rat ventricular myocyte model of hypertrophy, we found that pharmacologic inhibitors of ERIC activation preserve SERCA2 mRNA levels during hypertrophy. ERIC activation is sufficient to reduce SERCA2 mRNA. We determined that ERIC represses SERCA2 transcription via nuclear factor-kappaB (NFkB), and activation of NFkB is sufficient to reduce SERCA2 mRNA in cardiomyocytes. This work establishes novel connections between ERIC, NFkB, and SERCA2 repression during cardiac hypertrophy. This mechanism may have implications for the progression of hypertrophy to heart failure. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据